Objective:To review the prevalence and prognostic significance of fibroblast growth factor receptor 1 (FGFR1) amplification and to establish an association betw
Background:Patients with diabetes mellitus (DM) have a higher risk of thromboembolic events;however,the optimal duration of dual antiplatelet therapy (DAPT) rem